HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spectral domain high-definition optical coherence tomography in patients undergoing epiretinal membrane surgery.

AbstractBACKGROUND AND OBJECTIVE:
To evaluate possible advantages of spectral domain optical coherence tomography (SD-OCT) in epiretinal membranes.
PATIENTS AND METHODS:
Patients with idiopathic epiretinal membranes (ERMs) were examined before and after vitreoretinal surgery. Cirrus SD high-definition (HD)-OCT was compared with Stratus time domain OCT to find correlations with visual acuity (VA) and metamorphopsia.
RESULTS:
Five consecutive patients were enrolled. With Cirrus HD-OCT, it was possible to differentiate between the ERM and the retinal surface in all patients. In areas where the ERM was adherent, this differentiation was severely limited with Stratus OCT. We found no significant correlations between Cirrus OCT and Stratus OCT for retinal thickness and VA. However, we found a relationship between metamorphopsia and topographic maps of the internal limiting membrane.
CONCLUSION:
Cirrus HD-OCT improved the preoperative evaluation of ERMs, offered a topographic reconstruction of the vitreomacular interface, and improved identification of retinal structures.
AuthorsChristiane I Falkner-Radler, Carl Glittenberg, Susanne Binder
JournalOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye (Ophthalmic Surg Lasers Imaging) 2009 May-Jun Vol. 40 Issue 3 Pg. 270-6 ISSN: 1542-8877 [Print] United States
PMID19485291 (Publication Type: Comparative Study, Journal Article)
Topics
  • Aged
  • Epiretinal Membrane (diagnosis, physiopathology, surgery)
  • Female
  • Humans
  • Lens Implantation, Intraocular
  • Male
  • Middle Aged
  • Phacoemulsification
  • Prospective Studies
  • Retina (pathology)
  • Tomography, Optical Coherence (methods)
  • Vision Disorders (physiopathology)
  • Visual Acuity (physiology)
  • Vitrectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: